Scarica l'app Stockscreener
13.99
3.13%
-0.4483
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Eyepoint Inc Borsa (EYPT) Ultime notizie
Here’s Why EyePoint, Inc. (EYPT) Is Among the Best Get Rich Quick Stocks - Insider Monkey
Price to sales forward of EyePoint, Inc. – DUS:PV3B - TradingView
Guggenheim reiterates Buy on EyePoint stock, cites trial progress - Investing.com
EyePoint Pharmaceuticals outlines long-term retina strategy as a specialty biotech - AD HOC NEWS
EYPTEyePoint Inc Forecast, Target Price - Finviz
EyePoint CMO Ramiro Ribeiro sells $73,166 in company stock - Investing.com
Form 4 Eyepoint Pharmaceuticals Inc For: 2 July By Investing.com - Investing.com Canada
EyePoint CMO sells 4,875 shares after option exercise | EYPT Insider Trading - Stock Titan
Spruce Street Capital LP's EyePoint Inc(EYPT) Holding History - GuruFocus
EYPT Rated Buy by Chardan Capital -- Price Target Raised to $65. - GuruFocus
Did Broad Russell Growth Index Additions Just Reframe EyePoint’s (EYPT) Small-Cap Biotech Profile? - Sahm
Chardan Boosts Price Target on EyePoint Pharmaceuticals to $65 From $29, Keeps Buy Rating - marketscreener.com
Huge - Moomoo
Chardan Capital Maintains EyePoint(EYPT.US) With Buy Rating, Raises Target Price to $65 - Moomoo
EyePoint, Inc.(NasdaqGM: EYPT) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
EyePoint, Inc.(NasdaqGM: EYPT) added to Russell 2500 Growth Benchmark - marketscreener.com
Pivotal Clinical Trial Readouts On The Horizon; Keeping An Eye On EyePoint? - RTTNews
EyePoint, Inc.(NasdaqGM: EYPT) added to Russell 2000 Growth Benchmark - marketscreener.com
EyePoint, Inc.(NasdaqGM: EYPT) added to Russell 3000E Growth Benchmark - marketscreener.com
EyePoint, Inc.(NasdaqGM: EYPT) added to Russell Microcap Growth Benchmark Index - marketscreener.com
Enterprise value to EBITDA forward of EyePoint, Inc. – NASDAQ:EYPT - TradingView
EyePoint, Inc. Actuals & Estimates (NASDAQ:EYPT) - TradingView
Price to book forward of EyePoint, Inc. – NASDAQ:EYPT - TradingView
Price to book forward of EyePoint, Inc. – LS:A2QJRU - TradingView
EYPT Forecast — Price Target — Prediction for 2027 - TradingView
EyePoint, Inc. Actuals & Estimates (DUS:PV3B) - TradingView
EYPT Q1 2026 Earnings: Wider-than-Expected Loss as Clinical Expenses MountEPS Consistency Score - dars.gov.et
(EYPT) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Price to sales forward of EyePoint, Inc. – LS:A2QJRU - TradingView
EyePoint Inc (EYPT) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Enterprise value to revenue forward of EyePoint, Inc. – NASDAQ:EYPT - TradingView
Price to earnings forward of EyePoint, Inc. – LS:A2QJRU - TradingView
A2QJRU Forecast — Price Target — Prediction for 2027 - TradingView
Enterprise value to revenue forward of EyePoint, Inc. – LS:A2QJRU - TradingView
EyePoint Pharmaceuticals Inc (EYPT) Institutional Confidence - TradingKey
Guggenheim Maintains EyePoint(EYPT.US) With Buy Rating, Maintains Target Price $68 - Moomoo
EYPT Reiterated by Guggenheim -- Price Target Maintained at $68. - GuruFocus
Mizuho reiterates EyePoint stock rating on competitor timeline shift By Investing.com - Investing.com South Africa
Mizuho reiterates EyePoint stock rating on competitor timeline shift - Investing.com
Mizuho Securities Maintains EyePoint(EYPT.US) With Buy Rating, Maintains Target Price $36 - Moomoo
EyePoint stockholders approve incentive plan amendment and elect directors By Investing.com - Investing.com South Africa
EyePoint, Inc. Approves Executive Compensation and Amends 2023 Long-Term Incentive Plan in Latest 8-K Filing - Minichart
Form 8K Eyepoint Pharmaceuticals Inc For: 22 June By Investing.com - Investing.com Nigeria
EyePoint stockholders approve incentive plan amendment and elect directors - Investing.com
EyePoint (EYPT) investors approve 4.9M-share incentive plan increase and all 2026 AGM proposals - Stock Titan
EyePoint Pharmaceuticals Inc (EYPT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
symbol__ Stock Quote Price and Forecast - CNN
JonesTrading Maintains EyePoint(EYPT.US) With Buy Rating, Maintains Target Price $43 - Moomoo
EyePoint Pharmaceuticals Inc - TradingKey
EyePoint Pharmaceuticals Inc (EYPT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
EyePoint Pharmaceuticals Inc (EYPT) Valuation: PE, PB & Fair Value Analysis - TradingKey
EyePoint Pharmaceuticals Inc (EYPT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
EyePoint Pharmaceuticals Inc (EYPT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
EyePoint Pharmaceuticals Inc (EYPT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - The Manila Times
(EYPT) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
1.95%
2.70%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):